“Biochemistry Laboratory Shift Based on Common Terminology Criteria in Patients With Advanced Basal Cell Carcinoma Receiving Sonidegib 200 Mg Daily: Results from the 42-Month BOLT Study”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s181. Accessed October 13, 2025. https://skin.dermsquared.com/skin/article/view/2013.